Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 P192 | DOI: 10.1530/endoabs.110.P192

ECEESPE2025 Poster Presentations Adrenal and Cardiovascular Endocrinology (169 abstracts)

Congenital adrenal hyperplasia causing Gender dysphoria: The dilemma of being a boy or a girl?

Yasmine Abdelmeguid & Samar Elwan


Faculty of Medicine, Alexandria University, Pediatric Endocrinology and Diabetology, Alexandria, Egypt


JOINT3214

Introduction: In developed countries, female patients with classic forms of congenital adrenal hyperplasia (CAH) are diagnosed at birth or in early childhood, allowing prompt treatment with correct gender assignment. The impact of late diagnosis or late interventions of CAH on gender identity, sexual orientation and function has been previously described. Hence, we-herein- describe an unusual case of an 18-year-old CAH girl with gender dysphoria and deciding to be a male.

Objective: To demonstrate the dilemma of gender identity in female CAH patients with delayed interventions due to social and cultural issues.

Case summary: An 18-year-old patient born to consanguineous parents had presented in a southern Egyptian city with persistent vomiting, electrolyte disturbance, atypical genitalia noticed since birth, and was diagnosed with salt-wasting congenital adrenal hyperplasia. Treatment with prednisolone and mineralocorticoid was started. No gonads were palpable, virilization Prader IV staging. Ultrasonography of the abdomen and pelvis was done showing uterus, no testes, bilateral ovaries. Due to social problems, the patient was lost to follow-up. At the age of 12.5 years, patient sought medical advice with breast enlargement and did laparoscopy showing female internal genitalia, and confirmed there were no testes. Before planning for surgery, the patient had his/her first menstrual cycle through a common urogenital sinus. They gave the decision to the patient after being reared for 11.5 years as a male, and his parents and they asked for doing bilateral salpingo-oophorectomy and hysterectomy at the age of 13 years. Hence, it was preferred to be an infertile male rather than a fertile female. Intramuscular testosterone was given for 3 months only for further virilization. The patient presented to us at the age of 18 years on subdose of prednisolone (1.4 mg/m2 per day), stopped mineralocorticoid therapy since 5 years. On examination, she/he had short stature, Breast Tanner 5, penile hypospadias (not operated), SPL 6 cm, stria rubra, and chordae. Moreover, body image discomfort, depressive symptoms, and gender dysphoria.

Conclusion: Social and cultural issues play a major role in the management of female CAH patients, whether as physicians we agree with or disagree. Disregarding CAH patients’ clinical condition, and deprivation of medical care have major consequences psychologically and physically.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches